Detalhe da pesquisa
1.
Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets.
J Biomed Sci
; 26(1): 77, 2019 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31629402
2.
Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma.
Biochem Biophys Res Commun
; 493(1): 14-19, 2017 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28939040
3.
Suberoylanilide hydroxamic acid represses glioma stem-like cells.
J Biomed Sci
; 23(1): 81, 2016 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27863490
4.
Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma.
Neuro Oncol
; 22(10): 1439-1451, 2020 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32328646
5.
Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase.
Redox Biol
; 13: 655-664, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28822335